These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11721741)

  • 1. The novel calpain inhibitor SJA6017 improves functional outcome after delayed administration in a mouse model of diffuse brain injury.
    Kupina NC; Nath R; Bernath EE; Inoue J; Mitsuyoshi A; Yuen PW; Wang KK; Hall ED
    J Neurotrauma; 2001 Nov; 18(11):1229-40. PubMed ID: 11721741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model.
    Thompson SN; Carrico KM; Mustafa AG; Bains M; Hall ED
    J Neurotrauma; 2010 Dec; 27(12):2233-43. PubMed ID: 20874056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice.
    Thompson SN; Gibson TR; Thompson BM; Deng Y; Hall ED
    Exp Neurol; 2006 Sep; 201(1):253-65. PubMed ID: 16814284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model.
    Bains M; Cebak JE; Gilmer LK; Barnes CC; Thompson SN; Geddes JW; Hall ED
    J Neurochem; 2013 Apr; 125(1):125-32. PubMed ID: 23216523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis.
    Saatman KE; Zhang C; Bartus RT; McIntosh TK
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):66-73. PubMed ID: 10616794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mu-calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury.
    Kampfl A; Posmantur R; Nixon R; Grynspan F; Zhao X; Liu SJ; Newcomb JK; Clifton GL; Hayes RL
    J Neurochem; 1996 Oct; 67(4):1575-83. PubMed ID: 8858942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.
    Pike BR; Flint J; Dutta S; Johnson E; Wang KK; Hayes RL
    J Neurochem; 2001 Sep; 78(6):1297-306. PubMed ID: 11579138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat.
    Newcomb JK; Kampfl A; Posmantur RM; Zhao X; Pike BR; Liu SJ; Clifton GL; Hayes RL
    J Neurotrauma; 1997 Jun; 14(6):369-83. PubMed ID: 9219852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury.
    Deng Y; Thompson BM; Gao X; Hall ED
    Exp Neurol; 2007 May; 205(1):154-65. PubMed ID: 17349624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats.
    Pike BR; Flint J; Dave JR; Lu XC; Wang KK; Tortella FC; Hayes RL
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):98-106. PubMed ID: 14688621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimmunophilin ligand V-10,367 is neuroprotective after 24-hour delayed administration in a mouse model of diffuse traumatic brain injury.
    Kupina NC; Detloff MR; Dutta S; Hall ED
    J Cereb Blood Flow Metab; 2002 Oct; 22(10):1212-21. PubMed ID: 12368660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat.
    Posmantur R; Kampfl A; Siman R; Liu J; Zhao X; Clifton GL; Hayes RL
    Neuroscience; 1997 Apr; 77(3):875-88. PubMed ID: 9070759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion.
    McGinn MJ; Kelley BJ; Akinyi L; Oli MW; Liu MC; Hayes RL; Wang KK; Povlishock JT
    J Neuropathol Exp Neurol; 2009 Mar; 68(3):241-9. PubMed ID: 19225412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure.
    Warren MW; Zheng W; Kobeissy FH; Cheng Liu M; Hayes RL; Gold MS; Larner SF; Wang KK
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):479-89. PubMed ID: 16882358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dicyclomine, an M1 muscarinic antagonist, reduces biomarker levels, but not neuronal degeneration, in fluid percussion brain injury.
    Cox CD; West EJ; Liu MC; Wang KK; Hayes RL; Lyeth BG
    J Neurotrauma; 2008 Nov; 25(11):1355-65. PubMed ID: 19061379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells.
    Nath R; Davis M; Probert AW; Kupina NC; Ren X; Schielke GP; Wang KK
    Biochem Biophys Res Commun; 2000 Jul; 274(1):16-21. PubMed ID: 10903889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of SJA6017, a calpain inhibitor, in rat spinal cord injury.
    Akdemir O; Uçankale M; Karaoğlan A; Barut S; Sağmanligil A; Bilguvar K; Cirakoğlu B; Sahan E; Colak A
    J Clin Neurosci; 2008 Oct; 15(10):1130-6. PubMed ID: 18656362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
    Pineda JA; Lewis SB; Valadka AB; Papa L; Hannay HJ; Heaton SC; Demery JA; Liu MC; Aikman JM; Akle V; Brophy GM; Tepas JJ; Wang KK; Robertson CS; Hayes RL
    J Neurotrauma; 2007 Feb; 24(2):354-66. PubMed ID: 17375999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses.
    Fukiage C; Azuma M; Nakamura Y; Tamada Y; Nakamura M; Shearer TR
    Biochim Biophys Acta; 1997 Oct; 1361(3):304-12. PubMed ID: 9375805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.
    Mustafa AG; Wang JA; Carrico KM; Hall ED
    J Neurochem; 2011 May; 117(3):579-88. PubMed ID: 21361959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.